NCT01579422
- Conditions
- Mental Disorders, Psychosis, Psychotic Disorders, +2 more
- Locations
-
- VA Connecticut Healthcare System West Haven, Connecticut, United States
Clinical trial condition
Schizophrenia
Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.
2,320 public trials
177 recruiting studies
Schizophrenia trial results
NCT02281162
- Conditions
- Avitaminosis, Deficiency Diseases, Glucose Metabolism Disorders, +11 more
- Locations
-
- Alegent Creighton Clinic - Psychiatric Associates (Dodge Street) Omaha, Nebraska, United States
NCT00108303
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- VA Eastern Colorado Health Care System, Denver Denver, Colorado, United States
NCT01869660
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Numazu Chuou Hospital Numazu, Shizuoka, Japan
NCT02054702
- Conditions
- Mental Disorders, Psychotic Disorders, Schizophrenia, +1 more
- Locations
-
Not specified
NCT00615511
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- University of Medicine & Dentistry of New Jersey- University Behavioral HealthCare Piscataway, New Jersey, United States
- Weill Medical College of Cornell University New York, United States
- Weill Medical College of Cornell University White Plains, New York, United States
Completed
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
NCT00356317
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- University of Miami Coral Gables, Florida, United States
NCT01689389
- Conditions
- Bipolar Episodes, Mental Disorders, Schizophrenia, +1 more
- Locations
-
- Research Site Argenteuil, France
- Research Site Belley, France
- Research Site Castelmaurou, France
- Reserach Site Cavaillon, France
Completed
Regulation of Arginine-vasopressin (AVP)
NCT02626832
- Conditions
- Behavior, Behavioral Symptoms, Depression, +12 more
- Locations
-
- The John Pierce Laboratory New Haven, Connecticut, United States
- VA Connecticut Healthcare System West Haven, Connecticut, United States
Completed
Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia
NCT02062190
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- HCPA Porto Alegre, Rio Grande do Sul, Brazil